基于网络药理学与分子对接探讨铁皮石斛抗疲劳的作用机制
Exploring the Anti-Fatigue Mechanism of Dendrobium officinale Based on Network Pharmacology and Molecular Docking
DOI: 10.12677/tcm.2026.154193, PDF,    科研立项经费支持
作者: 林 潇, 王宗煜, 许先源, 陈子颜, 赵子建:广西中医药大学赛恩斯新医药学院,广西 南宁;杨汉立, 段雪琳*:广西中医药大学壮医药学院,广西 南宁
关键词: 铁皮石斛疲劳网络药理学分子对接Dendrobium officinale Fatigue Network Pharmacology Molecular Docking
摘要: 目的:通过网络药理学和分子对接技术探讨铁皮石斛抗疲劳的作用机制。方法:先通过文献挖掘筛选铁皮石斛的活性成分,再借助SwissTargetPrediction数据库获取这些成分的作用靶点;同时利用OMIM、GeneCards、Drugbank数据库挖掘疲劳相关靶点,将两类靶点的交集作为潜在作用靶点开展后续分析。随后采用STRING数据库构建蛋白互作(PPI)网络,通过DAVID数据库进行GO和KEGG通路富集分析,最后运用Cytoscape、Pymol软件完成分子对接。结果:共得到铁皮石斛有效活性成分14个,相关靶点377个,疾病靶点915个,两者共有57个交集。GO功能富集结果显示,“潜在作用靶点”主要涉及胰岛素样生长因子受体信号通路、表皮生长因子受体信号通路等生物过程;细胞质膜、受体复合物等细胞成分;蛋白酪氨酸激酶活性、组蛋白H2AX Y142激酶活性等分子功能。KEGG富集分析显示,潜在作用靶点涉及的通路包括参与癌症中的中央碳代谢、非小细胞肺癌、癌症中的信号通路等。根据分子对接结果可见,潜在作用靶点的蛋白结构与活性成分结合情况良好。结论:铁皮石斛能通过多种途径发挥抗疲劳的功效。
Abstract: Objective: To investigate the anti-fatigue mechanism of Dendrobium officinale using network pharmacology and molecular docking techniques. Methods: Active components of Dendrobium officinale were searched and screened through literature mining, and their action targets were obtained from the SwissTargetPrediction database. Meanwhile, fatigue-related targets were obtained from the OMIM, GeneCards, and Drugbank databases, and the intersection of the two sets of targets was identified as potential action targets for further analysis. A protein-protein interaction (PPI) network was constructed using the STRING database, and GO and KEGG enrichment analyses were conducted using the DAVID database. Finally, molecular docking was performed using Cytoscape and Pymol software. Results: A total of 14 effective active components of Dendrobium officinale were identified, with 377 related targets and 915 disease targets, yielding an intersection of 57. The GO functional enrichment results indicated that the “potential action targets” mainly involve biological processes such as the insulin-like growth factor receptor signaling pathway and epidermal growth factor receptor signaling pathway; cellular components like the cytoplasmic membrane and receptor complex; and molecular functions such as protein tyrosine kinase activity and histone H2AX Y142 kinase activity. The KEGG enrichment analysis indicated that potential targets were associated with pathways including central carbon metabolism in cancer, non-small cell lung cancer, and signaling pathways in cancer. According to molecular docking results, the protein structure of the potential action targets exhibits a good binding situation with the active components. Conclusion: Dendrobium officinale can exert anti-fatigue effects through multiple pathways.
文章引用:林潇, 王宗煜, 许先源, 陈子颜, 赵子建, 杨汉立, 段雪琳. 基于网络药理学与分子对接探讨铁皮石斛抗疲劳的作用机制[J]. 中医学, 2026, 15(4): 143-155. https://doi.org/10.12677/tcm.2026.154193

参考文献

[1] 殷恒泽. 大复方“三合汤”治疗慢性疲劳综合征32例[J]. 上海中医药杂志, 1999(3): 20-21.
[2] 戴忠华, 笪舫芳, 朱华, 等. 《中华人民共和国药典》(一部)中石斛药材的演变[J]. 中华中医药学刊, 2017, 35(2): 370-372.
[3] 邓捷, 付香玉, 赵德强, 等. 石斛多糖对小鼠体内血糖、血脂浓度、免疫功能及抗疲劳能力的影响[J]. 食品研究与开发, 2025, 46(6): 88-95.
[4] Glaister, M. (2005) Multiple Sprint Work: Physiological Responses, Mechanisms of Fatigue and the Influence of Aerobic Fitness. Sports Medicine, 35, 757-777.
[5] Zhang, X.Y., Jing, S., Lin, H.J., et al. (2019) Anti-Fatigue Effect of Anwulignan via the NRF2 and PGC-1α Signaling Pathway in Mice. Food & Function, 10, 7755-7766. [Google Scholar] [CrossRef] [PubMed]
[6] 王婵, 杨颖博. 荷叶的化学成分与药理活性研究进展[J]. 现代中药研究与实践, 2020, 34(4): 74-81.
[7] 徐曙, 赵兴增, 周倩, 等. 甘草根中黄酮类化合物的提取、分离与衍生化及其抑菌活性研究[J]. 植物资源与环境学报, 2020, 29(6): 32-41.
[8] 王宜平, 刘犇, 郑文亚. 柚皮素的生物学功能及其在畜禽生产中的应用[J]. 动物营养学报, 2024, 36(12): 7601-7612.
[9] 郝冰. Desmodium incanum根化感物质黄酮碳苷的生物合成与相关糖基转移酶底物专一性研究[D]: [博士学位论文]. 咸阳: 西北农林科技大学, 2016.
[10] 黄琴, 沈杨霞, 张成静, 等. 铁皮石斛多酚和黄酮含量及与抗氧化活性的相关性[J]. 应用与环境生物学报, 2014, 20(3): 438-442.
[11] 卢琦, 邹林峰, 高远真, 等. 甘草素对长波紫外线诱导的皮肤光老化的保护作用及机制[J]. 中国新药杂志, 2022, 31(20): 2056-2066.
[12] Kumar, R.P. and Abraham, A. (2016) PVP-Coated Naringenin Nanoparticles for Biomedical Applications—In Vivo Toxicological Evaluations. Chemico-Biological Interactions, 257, 110-118. [Google Scholar] [CrossRef] [PubMed]
[13] Heo, H.J., Kim, D., Shin, S.C., Kim, M.J., Kim, B.G. and Shin, D. (2004) Effect of Antioxidant Flavanone, Naringenin, Fromcitrus Junoson Neuroprotection. Journal of Agricultural and Food Chemistry, 52, 1520-1525. [Google Scholar] [CrossRef] [PubMed]
[14] Rehman, K., Khan, I.I., Akash, M.S.H., et al. (2020) Naringenin Downregulates Inflammation-Mediated Nitric Oxide Overproduction and Potentiates Endogenous Antioxidant Status during Hyperglycemia. Journal of Food Biochemistry, 44, e13422.
[15] Siddika, T., Balasuriya, N., Frederick, M.I., Rozik, P., Heinemann, I.U. and O’Donoghue, P. (2022) Delivery of Active AKT1 to Human Cells. Cells, 11, Article 3834. [Google Scholar] [CrossRef] [PubMed]
[16] 杨艳荣, 郑先雷, 李洪洋. AKT1表达与非小细胞肺癌临床病理特征及预后的关系[J]. 实用癌症杂志, 2021, 36(3): 364-367.
[17] Brogowska, K.K., Zajkowska, M. and Mroczko, B. (2023) Vascular Endothelial Growth Factor Ligands and Receptors in Breast Cancer. Journal of Clinical Medicine, 12, Article 2412. [Google Scholar] [CrossRef] [PubMed]
[18] Sabbah, D.A., Hajjo, R. and Sweidan, K. (2020) Review on Epidermal Growth Factor Receptor (EGFR) Structure, Signaling Pathways, Interactions, and Recent Updates of EGFR Inhibitors. Current Topics in Medicinal Chemistry, 20, 815-834. [Google Scholar] [CrossRef] [PubMed]
[19] Canaud, G., Hammill, A.M., Adams, D., Vikkula, M. and Keppler-Noreuil, K.M. (2021) A Review of Mechanisms of Disease across PIK3CA-Related Disorders with Vascular Manifestations. Orphanet Journal of Rare Diseases, 16, Article No. 306. [Google Scholar] [CrossRef] [PubMed]
[20] Castillo, S.D., Tzouanacou, E., Zaw-Thin, M., Berenjeno, I.M., Parker, V.E.R., Chivite, I., et al. (2016) Somatic Activating Mutations in Pik3ca Cause Sporadic Venous Malformations in Mice and Humans. Science Translational Medicine, 8, 332ra43. [Google Scholar] [CrossRef] [PubMed]
[21] Jansen, L.A., Mirzaa, G.M., Ishak, G.E., O’Roak, B.J., Hiatt, J.B., Roden, W.H., et al. (2015) PI3K/AKT Pathway Mutations Cause a Spectrum of Brain Malformations from Megalencephaly to Focal Cortical Dysplasia. Brain, 138, 1613-1628. [Google Scholar] [CrossRef] [PubMed]
[22] Keppler-Noreuil, K.M., Sapp, J.C., Lindhurst, M.J., et al. (2014) Clinical Delineation and Natural History of the PIK3CA-Related Overgrowth Spectrum. American Journal of Medical Genetics Part A, 7, 1713-1733.
[23] Kurek, K.C., Luks, V.L., Ayturk, U.M., Alomari, A.I., Fishman, S.J., Spencer, S.A., et al. (2012) Somatic Mosaic Activating Mutations in PIK3CA Cause CLOVES Syndrome. The American Journal of Human Genetics, 90, 1108-1115. [Google Scholar] [CrossRef] [PubMed]
[24] Rios, J.J., Paria, N., Burns, D.K., Israel, B.A., Cornelia, R., Wise, C.A., et al. (2013) Somatic Gain-of-Function Mutations in PIK3CA in Patients with Macrodactyly. Human Molecular Genetics, 22, 444-451. [Google Scholar] [CrossRef] [PubMed]
[25] Rivière, J.B., Mirzaa, G.M., O’Roak, B.J., et al. (2012) De Novo Germline and Postzygotic Mutations in AKT3, PIK3R2 and PIK3CA Cause a Spectrum of Related Megalencephaly Syndromes. Nature Genetics, 44, 934-940.
[26] Rodriguez-Laguna, L., Agra, N., Ibañez, K., Oliva-Molina, G., Gordo, G., Khurana, N., et al. (2019) Somatic Activating Mutations in PIK3CA Cause Generalized Lymphatic Anomaly. Journal of Experimental Medicine, 216, 407-418. [Google Scholar] [CrossRef] [PubMed]
[27] Vahidnezhad, H., Youssefian, L. and Uitto, J. (2016) Klippel-Trenaunay Syndrome Belongs to the PIK3CA-Related Overgrowth Spectrum (PROS). Experimental Dermatology, 25, 17-19. [Google Scholar] [CrossRef] [PubMed]
[28] Bachman, K.E., Argani, P., Samuels, Y., Silliman, N., Ptak, J., Szabo, S., et al. (2004) The PIK3CA Gene Is Mutated with High Frequency in Human Breast Cancers. Cancer Biology & Therapy, 3, 772-775. [Google Scholar] [CrossRef] [PubMed]
[29] Campbell, I.G., Russell, S.E., Choong, D.Y.H., Montgomery, K.G., Ciavarella, M.L., Hooi, C.S.F., et al. (2004) Mutation of the PIK3CA Gene in Ovarian and Breast Cancer. Cancer Research, 64, 7678-7681. [Google Scholar] [CrossRef] [PubMed]
[30] Fruman, D.A., Chiu, H., Hopkins, B.D., Bagrodia, S., Cantley, L.C. and Abraham, R.T. (2017) The PI3K Pathway in Human Disease. Cell, 170, 605-635. [Google Scholar] [CrossRef] [PubMed]
[31] Samuels, Y., Wang, Z., Bardelli, A., Silliman, N., Ptak, J., Szabo, S., et al. (2004) High Frequency of Mutations of the PIK3CA Gene in Human Cancers. Science, 304, 554-554. [Google Scholar] [CrossRef] [PubMed]
[32] Kim, H. and Delarue, M. (2025) Dynamic Structure of the Cytoplasm. Current Opinion in Cell Biology, 94, Article 102507. [Google Scholar] [CrossRef] [PubMed]
[33] Ji, L., Xu, F., Zhang, J., Song, T., Chen, W., Yin, X., et al. (2022) ADRB2 Expression Predicts the Clinical Outcomes and Is Associated with Immune Cells Infiltration in Lung Adenocarcinoma. Scientific Reports, 12, Article No. 15994. [Google Scholar] [CrossRef] [PubMed]
[34] Constantin-Teodosiu, D. and Constantin, D. (2021) Molecular Mechanisms of Muscle Fatigue. International Journal of Molecular Sciences, 22, Article 11587. [Google Scholar] [CrossRef] [PubMed]